[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"observational\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:observational":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":28,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":5},"100305234","prospective-observational-trial-to-evaluate-quality-of-life-after-stereotactic-ablative-radiation-therapy-in-patients-with-hepatocellular-carcinoma-100305234",false,"NCT03253536","Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma","LIVERCARE","Inclusion Criteria:\n\n* histologically or radiologically proven hepatocellular carcinoma\n* 1-3 lesions suitable for stereotactic radiation therapy\n* indication for SBRT according to multidisciplinary board evaluation\n* age \\>= 18 years\n* written informed consent for study participation\n* mental and verbal ability to complete standardized questionaires according to assessment by investigator (physician)\n\nExclusion Criteria:\n\n* age \\\u003C 18 years\n* prior HCC specific systemic therapy\n* concurrent oncological systemic treatment\n* distant metastases\n* inadequate ability tobe compliant with the protocol or to complete standardizes questionaires\n* inability to receive contrast-enhanced planning CT\n* missing ability to give informed consent\n* legal custody","ALL","18 Years",{"count":19,"type":20},100,"ESTIMATED","OBSERVATIONAL","Prospective single arm, single center observational study to evaluate Quality of Life (Qol) after stereotactic body radiotherapy for patients with hepatocellular cancer. Patients will receive work-up, treatment and follow-up exclusively as routinely done except additional quality of life measurements. Qol will be measured by standardized and validated EORTC questionaires at different time points during routine follow-up.",[24,25,26,27],"Hepatocellular Cancer","Quality of Life","Stereotactic Body Radiation Therapy","Observational",[24,25,29,30],"stereotactic body radiation therapy","observational","RECRUITING","2017-08-16",{"date":34,"type":35},"2017-08-18","ACTUAL",{"date":37,"type":35},"2017-07-10",{"date":39,"type":20},"2027-07-10",{"name":41,"class":42},"Ludwig-Maximilians - University of Munich","OTHER"]